Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.
Standard
Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study. / Schoemaker, J; Stet, L; Vrijland, P; Naber, Dieter; Panagides, J; Emsley, R.
In: PHARMACOPSYCHIATRY, Vol. 45, No. 5, 5, 2012, p. 196-203.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Long-term efficacy and safety of asenapine or olanzapine in patients with schizophrenia or schizoaffective disorder: an extension study.
AU - Schoemaker, J
AU - Stet, L
AU - Vrijland, P
AU - Naber, Dieter
AU - Panagides, J
AU - Emsley, R
PY - 2012
Y1 - 2012
N2 - Safety and efficacy results, collected in schizophrenia and schizoaffective disorder patients treated for up to nearly 3 years, are presented for asenapine and olanzapine.
AB - Safety and efficacy results, collected in schizophrenia and schizoaffective disorder patients treated for up to nearly 3 years, are presented for asenapine and olanzapine.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Psychiatric Status Rating Scales
KW - Treatment Outcome
KW - Longitudinal Studies
KW - Dose-Response Relationship, Drug
KW - Diagnostic and Statistical Manual of Mental Disorders
KW - Time
KW - Drug Monitoring
KW - Pharmacovigilance
KW - Comparative Effectiveness Research
KW - Antipsychotic Agents/administration & dosage/adverse effects
KW - Basal Ganglia Diseases/chemically induced
KW - Benzodiazepines/administration & dosage/adverse effects
KW - Heterocyclic Compounds with 4 or More Rings/administration & dosage/adverse effects
KW - Psychotic Disorders/diagnosis/drug therapy
KW - Schizophrenia/diagnosis/drug therapy
KW - Weight Gain/drug effects
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Middle Aged
KW - Psychiatric Status Rating Scales
KW - Treatment Outcome
KW - Longitudinal Studies
KW - Dose-Response Relationship, Drug
KW - Diagnostic and Statistical Manual of Mental Disorders
KW - Time
KW - Drug Monitoring
KW - Pharmacovigilance
KW - Comparative Effectiveness Research
KW - Antipsychotic Agents/administration & dosage/adverse effects
KW - Basal Ganglia Diseases/chemically induced
KW - Benzodiazepines/administration & dosage/adverse effects
KW - Heterocyclic Compounds with 4 or More Rings/administration & dosage/adverse effects
KW - Psychotic Disorders/diagnosis/drug therapy
KW - Schizophrenia/diagnosis/drug therapy
KW - Weight Gain/drug effects
M3 - SCORING: Journal article
VL - 45
SP - 196
EP - 203
JO - PHARMACOPSYCHIATRY
JF - PHARMACOPSYCHIATRY
SN - 0176-3679
IS - 5
M1 - 5
ER -